Clinical trial

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

NCT00001026

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention gp160 Vaccine (Immuno-AG) Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention rgp120/HIV-1IIIB Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention rgp120/HIV-1MN Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention rgp120/HIV-1 SF-2 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention HIVAC-1e Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE1

Conditions

HIV Infectionsunresolved

Interventions

gp160 Vaccine (Immuno-AG)BIOLOGICAL

rgp120/HIV-1IIIBBIOLOGICAL

rgp120/HIV-1MNBIOLOGICAL

rgp120/HIV-1 SF-2BIOLOGICAL

HIVAC-1eBIOLOGICAL

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

SeattleWashington, United States1 RochesterNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00001026 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.